Want to join the conversation?
Sales from $ZBH's knee business grew in 3Q15 by 1.7%, reflecting positive volume and mix of 4% and negative price of 2.3%. Sales growth continued to be led by Persona: The Personalized Knee System and the clinically trusted Vanguard Complete Knee System as well as the Vanguard 360 Revision Knee System.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.